No abstract available
Keywords:
2015; ESGO; Gynecologic cancer; Meeting.
Publication types
-
Congress
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Aorta
-
Chemotherapy, Adjuvant
-
Drug Resistance, Neoplasm
-
Endometrial Neoplasms / chemistry
-
Endometrial Neoplasms / pathology
-
Endometrial Neoplasms / therapy*
-
Female
-
Humans
-
Hypoxia-Inducible Factor 1, alpha Subunit / analysis
-
Laparoscopy
-
Lymph Node Excision / adverse effects*
-
Lymphatic Metastasis
-
Lymphocele / etiology*
-
Neoplasm Recurrence, Local / drug therapy*
-
Ovarian Neoplasms / genetics
-
Ovarian Neoplasms / pathology
-
Ovarian Neoplasms / therapy*
-
Pelvis
-
Pregnancy
-
Prenatal Exposure Delayed Effects / chemically induced*
-
Second-Look Surgery
-
Uterine Cervical Neoplasms / therapy*
Substances
-
HIF1A protein, human
-
Hypoxia-Inducible Factor 1, alpha Subunit